India $46 Billion Pharmaceutical Giant Sun Pharma Buys United States Healthcare Company Organon for $11.75 Billion (Include Debt) in All-Cash Deal, Organon Founded in 1923 by Dr. Saal van Zwanenberg, Organon Current Market Value at $3.5 Billion, Share Price +85.6% YTD, +40.8% Last 12 Months & -57.1% Last 5 Years
2nd May 2026 | Hong Kong
India pharmaceutical giant Sun Pharma ($46 billion market value) has announced to buy United States healthcare company Organon for $11.75 billion in all-cash deal. Organon was founded in 1923 by Dr. Saal van Zwanenberg. Organon current market value at $3.5 billion, share price +85.6% YTD, +40.8% last 12 months & -57.1% last 5 years. Organon – Organon is a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. With a portfolio of over 70 products across Women’s Health and General Medicines, which includes biosimilars, Organon focuses on addressing health needs that uniquely, disproportionately or differently affect women, while expanding access to essential treatments in over 140 markets. Sun Pharma – Sun Pharma is the world’s fourth-largest speciality generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma’s global presence is supported by more than 40 manufacturing facilities spread across 5 continents, R&D centres across the globe, and a multicultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising around 3,000 scientists and R&D investments of over 6-8% of annual revenues.
“ India $46 Billion Pharmaceutical Giant Sun Pharma Buys United States Healthcare Company Organon for $11.75 Billion (Include Debt) in All-Cash Deal, Organon Founded in 1923 by Dr. Saal van Zwanenberg, Organon Current Market Value at $3.5 Billion, Share Price +85.6% YTD, +40.8% Last 12 Months & -57.1% Last 5 Years “
![](https://www.caproasia.com/wp-content/uploads/2025/08/Air-Charter-Service-728x90-1.png")
India $46 Billion Pharmaceutical Giant Sun Pharma Buys United States Healthcare Company Organon for $11.75 Billion (Include Debt) in All-Cash Deal, Organon Founded in 1923 by Dr. Saal van Zwanenberg, Organon Current Market Value at $3.5 Billion, Share Price +85.6% YTD, +40.8% Last 12 Months & -57.1% Last 5 Years
Caproasia Users
- Manage $20 million to $30 billion of assets
- Invest $3 million to $300 million
- Advise institutions, billionaires, UHNWs & HNWs
Caproasia Platforms | 11,000 Investors & Advisors
- Caproasia.com
- Caproasia Access
- Caproasia Events
- The Financial Centre | Find Services
- Membership
- Family Office Circle
- Professional Investor Circle
- Investor Relations Network
Monthly Roundtable & Networking
Family Office Programs
The 2026 Investment Day
- March - Hong Kong
- March - Singapore
- April - Hong Kong
- April - Singapore
- July - Hong Kong
- July - Singapore
- Sept- Hong Kong
- Sept - Singapore
- Oct- Hong Kong
- Nov - Singapore
- Visit: The Investment Day | Register: Click here
Caproasia Summits
- The Institutional Investor Summit
- The Investment / Alternatives Summit
- The Private Wealth Summit
- The Family Office Summit
- The CEO & Entrepreneur Summit
- The Capital Markets Summit
- The ESG / Sustainable Investment Summit
